Yipinhong Pharmaceutical Co Ltd Class A (300723) - Total Liabilities
Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has total liabilities worth CN¥2.61 Billion CNY (≈ $381.64 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Yipinhong Pharmaceutical Co Ltd Class A liquidity resilience to evaluate the company's liquid asset resilience ratio.
Yipinhong Pharmaceutical Co Ltd Class A - Total Liabilities Trend (2013–2025)
This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Yipinhong Pharmaceutical Co Ltd Class A's balance sheet.
Yipinhong Pharmaceutical Co Ltd Class A Competitors by Total Liabilities
The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Indraprastha Gas Limited
NSE:IGL
|
India | Rs55.17 Billion |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
USA | $15.29 Billion |
|
Berli Jucker PCL
BK:BJC
|
Thailand | ฿205.81 Billion |
|
BW LPG Limited
F:BW9
|
Germany | €1.23 Billion |
|
Zibo Qixiang Tengda Chemical Co Ltd
SHE:002408
|
China | CN¥12.41 Billion |
|
Helios Technologies Inc
NYSE:HLIO
|
USA | $575.30 Million |
|
Micro Tech Nanjing Co Ltd
SHG:688029
|
China | CN¥884.78 Million |
|
Patrick Industries Inc
NASDAQ:PATK
|
USA | $2.08 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Yipinhong Pharmaceutical Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Yipinhong Pharmaceutical Co Ltd Class A (300723) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yipinhong Pharmaceutical Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
The table below shows the annual total liabilities of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.64 Billion ≈ $385.66 Million |
+6.78% |
| 2024-12-31 | CN¥2.47 Billion ≈ $361.18 Million |
+36.56% |
| 2023-12-31 | CN¥1.81 Billion ≈ $264.48 Million |
-6.48% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.81 Million |
+14.63% |
| 2021-12-31 | CN¥1.69 Billion ≈ $246.72 Million |
+159.33% |
| 2020-12-31 | CN¥650.14 Million ≈ $95.14 Million |
+43.14% |
| 2019-12-31 | CN¥454.20 Million ≈ $66.46 Million |
-5.70% |
| 2018-12-31 | CN¥481.67 Million ≈ $70.48 Million |
+28.98% |
| 2017-12-31 | CN¥373.45 Million ≈ $54.65 Million |
-10.19% |
| 2016-12-31 | CN¥415.82 Million ≈ $60.85 Million |
-3.28% |
| 2015-12-31 | CN¥429.90 Million ≈ $62.91 Million |
-29.09% |
| 2014-12-31 | CN¥606.28 Million ≈ $88.72 Million |
+168.67% |
| 2013-12-31 | CN¥225.66 Million ≈ $33.02 Million |
-- |
About Yipinhong Pharmaceutical Co Ltd Class A
ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale a… Read more